Vermont HIE Tightens Integration With Public Health, Medicaid
VITL CEO Beth Anderson says the pandemic helped cement a bond between Vermont health information exchange and Department of Health
Read More
AI: A Good Tool to Combat Bad Actors in Healthcare
AI can be a highly effective tool for plans aiming to reduce fraud, waste and abuse, but only if it is combined with investigative intelligence. The post AI: A Good Tool to Combat Bad Actors in Healthcare appeared first on MedCity News.
The Future of Healthcare Apps Depends on AI-Assisted Development
AI-assisted software development can help teams achieve faster delivery, lower costs, and higher-quality results – all key to meeting patients’ and providers’ digital health expectations. The post The Future of Healthcare Apps Depends on AI-Assisted Development appeared first on MedCity News.
Blood Transfusions at the Scene Save Lives. But Ambulances Are Rarely Equipped To Do Them.
One August afternoon in 2023, Angela Martin’s cousin called with alarming news. Martin’s 74-year-old aunt had been mauled by four dogs while out for a walk near her home in rural Purlear, North Carolina. She was bleeding heavily from bites on both legs and her right arm, where she’d tried to protect her face and…
House Cats With Bird Flu Could Pose a Risk to Public Health
More than 80 domestic cats, among many other types of mammals, have been confirmed to have had bird flu since 2022 — generally barn cats that lived on dairy farms, as well as feral cats and pets that spend time outdoors and likely caught it by hunting diseased rodents or wild birds. Now, a small…
Could the Trump Administration Change the Medicare Drug Price Negotiation Program?
CMS recently issued a statement saying that it’s continuing the Medicare Drug Price Negotiation Program but is leaving the door open for potential changes. Experts weighed in on what changes could be made and what changes they would like to see. The post Could the Trump Administration Change the Medicare Drug Price Negotiation Program? appeared…
Vertex Pharma Challenger Sionna Secures $191M in IPO Cash for Cystic Fibrosis Pipeline
Sionna Therapeutics found strong investor interest in its cystic fibrosis drugs, which could rival blockbuster Vertex Pharmaceuticals product Trikafta. The biotech has three internally developed programs that hit a target unaddressed by any currently available CF therapies. The post Vertex Pharma Challenger Sionna Secures $191M in IPO Cash for Cystic Fibrosis Pipeline appeared first on…
Beyond Drugs: Blood-Based Therapies in Sickle Cell Disease and Beyond
At a moment when medication therapy for sickle cell disease (SCD) leaves too many behind and widespread access to curative gene therapies still lies in the distant future, automated red blood cell exchange is experiencing renewed interest. To improve patients’ lives, a broad commitment is needed to expand access to transfusion therapies. The post Beyond…
RFK’s Hearing: Inefficiencies in Government-Controlled Systems
Kennedy emphasized that these inefficiencies aren’t just administrative headaches, they’re costing lives. Nowhere is this more evident than in organ-transplant logistics: the way organs get assigned – and move – from donors to patient recipients. The post RFK’s Hearing: Inefficiencies in Government-Controlled Systems appeared first on MedCity News.